InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that data from the Phase 3 study of vilobelimab ...

Missouri lawmakers advanced legislation this week to create a clear pathway for adults with severe mental illness to receive ...

Posters presented at the 2026 AAD Annual Meeting examined bimekizumab for hidradenitis suppurative across various subgroups ...

The Marshall Police Department (MPD) had received reports of a child who had severe burns that were left untreated by the ...

WSU veterinarians implant a pacemaker to stop a Czech shepherd’s sudden collapses. During the peak of the COVID-19 pandemic, ...

Fundamental research into the mechanisms behind cancers at an institution in Japan is leading to new approaches for tackling these notoriously complex diseases. Every year, up to 20 million people in ...